Results 91 to 100 of about 23,898 (157)

Adherence to Antithrombotic Therapy for Patients Attending a Multidisciplinary Thrombosis Service in Canada – A Cross-Sectional Survey

, 2022
Kwadwo Osei Bonsu,1 Stephanie Young,1,2 Tiffany Lee,1,2 Hai Nguyen,1 Rufaro S Chitsike3,4 1School of Pharmacy, Memorial University of Newfoundland and Labrador, St John’s, NL, A1B 3V6, Canada; 2Pharmacy Program, Eastern Region Health Authority, St John’s,
Bonsu KO, Young S, Nguyen H, Chitsike RS, Lee T   +4 more
core  

Antithrombotic therapy at the end-of-life—continue or stop?

Research and Practice in Thrombosis and Haemostasis
Antithrombotics at the end-of-life pose a clinical challenge where indication-specific time-to-benefit, bleeding risk, and patient priorities must be reconciled over short prognostic horizons. In this review of the literature, we found that a substantial
Gerard Gurumurthy, Naisthika Kumar, Lianna Reynolds, Biddy Bassam, Marc Carrier, Simon Noble, Alok A. Khorana, Jecko Thachil   +7 more
doaj   +1 more source

Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement

, 2019
Antithrombotic therapy for stroke prevention in patients with atrial fibrillation (AF) has dramatically shifted from warfarin, a vitamin K antagonist, to the direct oral anticoagulants (DOACs) such as dabigatran, apixaban, and rivaroxaban.
Tania Ahuja, Scarlett Murphy, Daniel J. Sartori   +2 more
core   +1 more source

Marine-Fungus-Derived Natural Compound 4-Hydroxyphenylacetic Acid Induces Autophagy to Exert Antithrombotic Effects in Zebrafish

Marine Drugs
Marine natural products are important sources of novel drugs. In this study, we isolated 4-hydroxyphenylacetic acid (HPA) from the marine-derived fungus Emericellopsis maritima Y39–2. The antithrombotic activity and mechanism of HPA were reported for the
Shaoshuai Xin, Mengqi Zhang, Peihai Li, Lizhen Wang, Xuanming Zhang, Shanshan Zhang, Zhenqiang Mu, Houwen Lin, Xiaobin Li, Kechun Liu   +9 more
doaj   +1 more source

Interactions of antithrombotic herbal medicines with western cardiovascular drugs

, 2019
This is the supplementary data for “Interactions of antithrombotic herbal medicines with western cardiovascular ...
Hu, Y (via Mendeley Data), Hu, Yuanjia
core   +1 more source

Perioperative/Periprocedural Antithrombotic Management in Oral Health Procedures. A Prospective Observational Study

Dentistry Journal
Background/Objectives: This paper evaluates the incidence of thrombotic and/or hemorrhagic adverse events within 30 days after oral health procedures (OHPs) in patients taking antithrombotic agents.
María González-Zamora, Nagore Ambrosio, Raquel González, Paula Anguita, Ana Molina, David Herrera, Mariano Sanz, Francisco Marín, María Anguita-Gámez, Raquel Ferrandis, David Vivas, Manuel Anguita, Elena Figuero   +12 more
doaj   +1 more source

Left Atrial Appendage Occlusion and Post-procedural Antithrombotic Management

Left atrial appendage occlusion (LAAO) is an established alternative to oral anticoagulation for stroke prevention in atrial fibrillation. Antithrombotic therapy is used in the post-procedural period to prevent device-related thrombosis (DRT).
Jens Erik Nielsen-Kudsk, Anders Kramer, Kasper Korsholm, Nielsen-Kudsk, Jens Erik, Korsholm, Kasper, Berti, Sergio, Giuseppe Patti, Kramer, Anders, Patti, Giuseppe, Sergio Berti   +9 more
core   +1 more source

Antithrombotic therapy in children

, 2012
This chapter is divided into three parts. In the first section, the evidence showing that the interaction of antithrombotic agents with the hemostatic system of the young differs from adults is presented, as are the indications for and the monitoring ...
Andrew, Maureen, Monagle, Paul, Bovill, Edwin, Michelson, Alan D.   +3 more
core   +1 more source

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients

, 2015
Steen Husted1,2 1Department of Biomedicine, Centre for Clinical Pharmacology, Aarhus, 2Department of Medicine, Hospital Unit West, Herning, Denmark Abstract: Patients with acute coronary syndrome (ACS) represent a major clinical burden, because they ...
Husted S
core  

Antithrombotic therapy in complex percutaneous coronary intervention

Over the past decades, percutaneous coronary intervention (PCI) has become the most common modality for myocardial revascularisation, and it is increasingly used in patients with advanced coronary artery disease.
Montone, Rocco Antonio, Esposito, Giovanni, Sinagra, Gianfranco, Oliva, Angelo, Castiello, Domenico Simone, Gragnano, Felice, Fabris, Enrico, Pelliccia, Francesco, Indolfi, Ciro, Moscarella, Elisabetta, Piccolo, Raffaele, Filardi, Pasquale Perrone, The Working Group of Interventional Cardiology of The Italian Society Of Cardiology, Andò, Giuseppe, Niccoli, Giampaolo, Porto, Italo, Spaccarotella, Carmen Anna Maria, Cardiology of Italian Society of Cardiology, Working Group of Interventional, Calabrò, Paolo, Rosa, Salvatore De   +19 more
core   +1 more source